133 related articles for article (PubMed ID: 3947105)
1. [Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity].
Sakatoku H; Kawai K; Kamiya H; Sakurai M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):239-46. PubMed ID: 3947105
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner.
Ozyurt H; Yildirim Z; Kotuk M; Yilmaz HR; Yağmurca M; Iraz M; Söğüt S; Gergerlioglu S
J Appl Toxicol; 2004; 24(4):269-75. PubMed ID: 15300714
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice.
Fouad AA; Al-Sultan AI; Refaie SM; Yacoubi MT
Toxicology; 2010; 274(1-3):49-56. PubMed ID: 20510337
[TBL] [Abstract][Full Text] [Related]
4. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
Saad SY; Najjar TA; Alashari M
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
Koikawa Y
Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
Guo JH
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
[TBL] [Abstract][Full Text] [Related]
8. Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats.
Uehara T; Tsuchiya N; Masuda A; Torii M; Nakamura M; Yamate J; Maruyama T
J Appl Toxicol; 2008 Apr; 28(3):388-98. PubMed ID: 17685399
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
Goudie J; Chandra M; Lawrence GD; Williams P
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
12. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
14. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
[TBL] [Abstract][Full Text] [Related]
15. Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.
Hecquet B; Depadt G; Fournier C; Meynadier J
Anticancer Res; 1986; 6(1):65-9. PubMed ID: 3954334
[TBL] [Abstract][Full Text] [Related]
16. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study.
Dobyan DC
Anat Rec; 1985 Jul; 212(3):239-45. PubMed ID: 4061878
[TBL] [Abstract][Full Text] [Related]
17. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
[TBL] [Abstract][Full Text] [Related]
18. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
Campbell AB; Kalman SM; Jacobs C
Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
